Nexus - 0604 - New Times Magazine-pages

Page Content (OCR)

"HIV" or merely the chemical stimulants obligatory to "grow" the symptomatic infection. The results showed "there was no statisti- "HIV". Neither is there proof that low numbers of T4 cells are cally significant difference in clinical outcome between the two either necessary or sufficient to produce the clinical syn- therapeutic polic: ” In 1995, extended results of Concorde drome.’'?"* This is a view recently expressed by leading showed a significant increased risk of death among the patients HIV/AIDS scientists such as Dr Arthur Anderson from the US treated early. Army Medical Research Institute of Infectious Disease*’ and Dr However, despite these data, despite disclaimers that patients Zvi Grossman at the University of Tel Aviv. treated with AZT may continue to develop the AIDS diseases, In other words, the central tenet of the HIV theory—virus- that the side effects of AZT may mimic AIDS, and that AZT induced killing of immune cells leading to AIDS—is now being given to non-HIV-infected babies causes the AIDS-defining pneu- questioned by HIV/AIDS experts themselves. Nonetheless, and monia, PCP,” AZT continues to be the most commonly pre- despite so much evidence to the contrary, the orthodox view scribed anti-HIV drug. remains entrenched. In fact, since 1993, the low number of T4 Dr Donald Abrams, Professor of Medicine and Director of the cells has been enshrined in the 1993 CDC AIDS definition where- AIDS program at San Francisco General Hospital, said: "I have a by AIDS can be diagnosed without a disease. Just as "co-factors" large population of people who have chosen not to take any anti- were proposed to rescue the HIV theory in the mid 1980s, in July retrovirals... I've been following them since the very beginning... 1998 Chen and colleagues from the UCLA AIDS Institute, School They've watched all of their friends go on the antiviral bandwagon of Medicine, Los Angeles, reported evidence and die."* that "naturally non-infectious virus" or virus Indeed, even an elementary study of the "rendered defective" by "anti-HIV" drugs pharmacological literature reveals that AZT could still contribute to the loss of T4 cells cannot be an anti-HIV drug; it is toxic to all throughout the course of HIV disease.® In cells.”' In fact, what unites long-term sur- other words, "alive" or "dead", HIV causes vivors of AIDS is their resolve not to take immune deficiency. Such a proposal does "anti-retrovirals".°”” not augur well for the use or continued devel- In mid-1996, the latest drugs, the "pro- eee A oputosoxde | the central tenet of | ss hibies”Pl) yer oduct tive stress theory is the direct relationship the HIV theory _ possible combinations of "cocktails" with between high frequencies of passive anal A i ali AZT or similar drugs as "highly active anti- intercourse and the development of AIDS, as virus induced killing retroviral therapy" (HAART). Detailed data well as the fact that the only animal model of of immune cells leading on these drugs, of the kind usually reserved AIDS is non-infectious. Mice repeatedly _ i for medical practitioners, appear regularly in injected with foreign cellular proteins to AIDS . Is now glossy, multi-page advertisements in being questioned by develop a dramatic depletion of T4 cells gay men's magazines. i's sarcoma-like tumours, and HIV/AIDS experts At the July 1996 11th International themselves. and Kaposi's AIDS Conference, Time magazine "abundant" retrovirus-like particles appear in their spleens.” Thus AIDS Man of the Year David Ho predicted that scientists would "find new drugs diseases are followed by the production of retrovirus-like particles, and not the to wipe HIV out of the body within W198 other way around. three years, possibly within just one". To the uninitiated this may seem per- At the July 1998 XIIth AIDS confer- plexing, but it is well recognised that ence, Ho stated it will take at least 10 retroviral particles appear de novo in years of intense combination drug ther- cell cultures not previously infected, apy to kill off all the HIV in an infect- because all cells contain retroviral infor- ed person's body, but that a sizeable mation carried in the germ line DNA.” percentage of HIV patients will never Indeed, according to distinguished get close. Many patients cannot toler- retrovirologists such as Weiss and ate the untoward effects of these Temin, new retroviral DNA arises by rearrangement of cellular "cocktails", and measurements show that the DNA "viral" burden DNA, caused by many factors including pathological processes— —_ does not decrease significantly.”' According to Kaufmann et a view that concedes retroviruses an effect and not the cause of al.: "49% of people taking HAART, who were followed by the diseases.” Swiss HIV Cohort Study, did not have viral suppression, and sim- ilar data are emerging from other centres.""" THE RISE AND FALL OF "ANTI-HIV" DRUGS In the May 1998 Proceedings of the National Academy of It would take a second article to discuss AZT and the many Sciences, Dr William Paul, former Director of the National other "anti-HIV" drugs. Suffice it to say there is no scientific Institutes of Health's Office of AIDS Research, wrote: "...no mat- proof that such drugs kill "HIV" or cure AIDS, but there is ample _ ter how long a person is treated with anti-HIV drugs, there will evidence they are harmful.'****° always be new viruses...you will have to be treated forever... No In 1994, a double-blind randomised comparison of two policies one is getting cured... This bodes extremely poorly for combina- of AZT treatment (immediate and deferred) was reported (the tion therapy as something curative..."** Concorde trial). This involved 1,749 symptom-free, HIV-infected Dr Michael Saag, at the University of Alabama, Birmingham, individuals from centres in the UK, Ireland and France. The 347 USA, is responsible for the treatment of over 1,000 AIDS clinical endpoints (AIDS and death) outnumbered the total of patients. His treatment is state-of-the-art and his clinic is sought- those in all other published trials in symptom-free and early after by pharmaceutical companies to conduct trials on their being questioned by HIV/AIDS experts Lene | ve themselves. THE RISE AND FALL OF "ANTI-HIV" DRUGS It would take a second article to discuss AZT and the many other "anti-HIV" drugs. Suffice it to say there is no scientific proof that such drugs kill "HIV" or cure AIDS, but there is ample evidence they are harmful.'****° In 1994, a double-blind randomised comparison of two policies of AZT treatment (immediate and deferred) was reported (the Concorde trial). This involved 1,749 symptom-free, HIV-infected individuals from centres in the UK, Ireland and France. The 347 clinical endpoints (AIDS and death) outnumbered the total of those in all other published trials in symptom-free and early JUNE — JULY 1999 NEXUS - 33 ws the central tenet of to AIDS — is now